← Back to Events
Tier 1 Global Networking: High GENERAL CONCLUDED
Meeting on the — 2026 — Rome, Italy
Medical devices, diagnostics, imaging and digital technologies are making a significant impact on the lives of people around the globe. These advances are being made by scientists, entrepreneurs, academics, investors, and an entire community of medtech leaders and innovators. The
3 Presentations
1 Companies
Presentation data updated Jun 15, 2026, 9:50 AM UTC
Nova Event Impact Score
32 /100
- Media coverage 6/20
- Speaker quality 14/20
- Pipeline relevance 0/20
- Historical influence 10/20
- Company participation 2/20
Key Takeaways
Key Themes
generalPipeline announcementsPartnership deals
Key Companies
Eli Lilly; Boehringer Ingelheim; Sciwind Biosciences
Key Markets
Europe
Key Opportunities
Partnership dealsLicensing discussionsVendor selection
Investors & analysts
Key Data to Watch
PLENARY
Phase III RASolute 302 topline data
PRESENTATION
Phase 3 CHALLENGE trial (NCT00819208) results
PRESENTATION
Obesity readouts from Eli Lilly, Boehringer Ingelheim, and Sciwind Biosciences